Should Upcoming Earnings Expectations Require Action From Cardinal Health Stock Investors?
Cardinal Health (CAH) Faces An Earnings Test On A Modestly Undervalued View
IBD Stock Of The Day Tests New Buy Point As Indicators Suggest More Upside
Cardinal Health (CAH) Laps the Stock Market: Here's Why
Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280
UBS Maintains Buy on Cardinal Health, Raises Price Target to $295
Level AI's CX Advisory Board adds Shane Abeyratne, SVP at Cardinal Health
What to Expect From Cardinal Health’s Q1 2027 Earnings Report
Should Value Investors Buy Cardinal Health (CAH) Stock?
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex
Cardinal Health rises on extended CVS distribution deal
Cardinal Health Extends CVS Health Pharmaceutical Distribution Agreement Through 2032
Cardinal Health, McKesson Double Down on CVS Deals Through 2032
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5
Cardinal Health Affirms FY2027 Adj EPS Of $12.40-$12.60 vs $12.04 Est
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.